Searched for
BHARAT BIOTECH LTD
Info Edge says it invested Rs 1,003 crore on AI, deeptech startups since 2020Info Edge, the parent of Naukri, has significantly boosted its AI and deeptech investments, pouring Rs 1,003 crore into 54 startups since 2...- Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...
- Two Trades for Today: A maker of forged components for a 7.7% gain, a mid-cap pharma stock for a 6% upmoveOur technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- Ahead of Market: 10 things that will decide stock market action on ThursdayIndian equities lost momentum after a positive start, with Nifty closing lower and broader markets declining sharply. Investor caution ahea...
- Ahead of Market: 10 things that will decide stock market action on WednesdayIndian equities ended higher on Tuesday, supported by easing geopolitical tensions and softer crude prices. A sharp drop in India VIX boost...
- Shastra VC launches $100 million fund to back deeptech, AI startupsThe Bengaluru-based firm said the new vehicle will invest between $500,000 and $3 million in IP-led firms across these sectors. The launch ...
- Tata Chemicals CEO R Mukundan takes over as CII president for 2026-27R Mukundan, CEO of Tata Chemicals, has assumed the presidency of the Confederation of Indian Industry (CII) for 2026-27, succeeding Rajiv M...
- Vaccine maker Bharat Biotech said to mull $500 million IPOIndian vaccine developer Bharat Biotech International Ltd. is considering an initial public offering that may raise more than $500 million,...
- Bharat Biotech, Biofabri in tech transfer deal for TB vaccineMTBVAC, the TB vaccine, has undergone Phase I and II clinical trials in India. The vaccine has demonstrated safety and immunogenicity. Base...
- Bharat Biotech inks pact with Alopexx for anti-microbial vaccineBharat Biotech has partnered with Alopexx, Inc. to co-develop and commercialize the anti-microbial vaccine AV0328 in India and other low-in...
- Bharat Biotech launches oral cholera vaccine Hillchol after positive phase 3 trialBharat Biotech unveiled Hillchol, a new single-strain oral cholera vaccine, developed with Hilleman Laboratories. Addressing the high globa...
- Bharat Biotech credited ICMR, NIV as Covaxin co-inventors after missing them initially: GovernmentResponding to Trinamool Congress member Sougata Roy, who had asked whether the government took any punitive action against the company for ...
- Bharat Biotech, Bilthoven Biologicals collaborate for oral polio vaccines production, supplyBharat Biotech on Tuesday said it has collaborated with the Netherlands-based Bilthoven Biologicals B.V, a wholly-owned arm of Serum Instit...
- Japan recognises Covaxin to facilitate travel from April 10: Bharat BiotechJapan has included Bharat Biotech's Covaxin in the list of recognised vaccines, a move aimed at facilitating travel between the two countri...
- Decision on Bharat Biotech's Covaxin EUL in October, says WHOThe latest 'Status of COVID-19 vaccines within WHO EUL/PQ evaluation process' guidance document dated September 29 on the WHO website said ...
- Covaxin receives GMP certificate from Hungary: Bharat BiotechBharat Biotech intends to submit documentation for emergency use authorisation to several additional countries worldwide, the company said.
- COVAXIN: News reports on submitting Phase-3 data to WHO is incorrect, says Bharat BiotechBharat Biotech's pre-submission meeting has been scheduled on June 23 for evaluation of the World Health Organisation (WHO)'s Emergency Use...
- Bharat Biotech's top brass calls on vice presidentThe indigenous, inactivated vaccine is being developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety Level 3) bio-containment faci...
- Bharat Biotech completes recruitment of 13,000 volunteers for Phase III trials of CovaxinBharat Biotech has signed up 13,000 volunteers for the Phase 3 trial, backed by India's government medical research body, and is progressin...
- Bharat Biotech begins Phase-III trials for COVID-19 vaccine, Covaxin, with 26,000 volunteers"This is India's first phase-III efficacy study for a Covid-19 vaccine, and the largest phase-III efficacy trial ever conducted in India," ...
Load More
